New and Emerging Therapies, Part 2
from HeadWise
Dr. Timothy Smith and Dr. Lindsay Weitzel compare and contrast three oral gepants, an IV monoclonal antibody, two combination therapies, and an anti-inflammatory agent, all expected to be available for the treatment of migraine very soon. For more information visit www.headaches.org
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of HeadWise?
This episode is 29 minutes long.
When was this HeadWise episode published?
This episode was published on January 21, 2021.
Can I download this HeadWise episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.